Open AccessNuvaRing: a vaginal contraceptive
Author(s) -
Kubba Ali,
Lete Ignacio,
Briggs Paula
Publication year - 2010
Publication title -
trends in urology, gynaecology & sexual health
Language(s) - English
Resource type - Journals
eISSN - 1931-2288
pISSN - 1362-5306
DOI - 10.1002/tre.135
Subject(s) - vaginal ring , medicine , pill , gynecology , tolerability , desogestrel , appeal , family planning , population , obstetrics , family medicine , alternative medicine , research methodology , nursing , environmental health , pathology , political science , law
Abstract Although the combined oral contraceptive pill is by far the most widely prescribed contraceptive option, it does not suit all women and, being user‐dependent, tends to fail women who cannot stick to a daily routine. NuvaRing is a vaginal contraceptive, a hormone‐containing ring that has shown good efficacy and tolerability. Its alternative method of delivery may appeal to younger women, thus helping to reduce the high rate of unplanned pregnancy in the UK. In this expert panel discussion, three specialists discuss the new product and its place as a contraceptive choice. The panel included Dr Ignacio Lete, a gynaecologist from Spain where NuvaRing has been widely used since 2003. Copyright © 2010 Wiley Interface Ltd